Fifth Industry-Wide Trial Master File Reference Model Survey is Now Open
Make sure your perspective is heard, and get valuable insights and data for your TMF improvement initiatives
Make sure your perspective is heard, and get valuable insights and data for your TMF improvement initiatives. An outgrowth of the volunteer TMF Reference Model initiative, this survey is designed to provide year-over-year TMF details from sponsors, CROs, inspectors, and sites, for both paper and electronic TMF management. The intent is to identify TMF trends, assess changes in industry directions, and measure the impact of TMF models. Survey link: https://www.surveymonkey.com/s/TMF2015.
Survey completion takes ten minutes or less, depending on your organization. All respondents who complete the survey and provide contact details will be sent the results; no respondent is identified in the results.
The TMF Survey has been developed by volunteer members of the TMF Reference Model initiative. Information about us can be found at the end of the survey, and also at: http://tmfrefmodel.com.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.
